Weight ManagementMarch 13, 2026·6 min read
By the CIRRUS Editorial Team — how we write and source this
GLP-1 medications explained: how semaglutide and tirzepatide work
These drugs have reshaped the weight management conversation. Here's the actual mechanism behind the headlines.
GLP-1 (glucagon-like peptide-1) is a naturally occurring gut hormone released after eating that signals satiety to the brain and slows gastric emptying — semaglutide and similar medications are synthetic versions engineered to remain active in the body far longer than the natural hormone, which typically breaks down within minutes.
Tirzepatide adds a second mechanism, also activating GIP (glucose-dependent insulinotropic polypeptide) receptors alongside GLP-1 — the dual mechanism appears to produce greater average weight loss in trials than GLP-1 activation alone, though individual response varies considerably.
The appetite effect operates at multiple levels — slowed gastric emptying contributes to feeling full longer after meals, while the brain-signaling effect appears to independently reduce food-related reward response and hunger cues, which is part of why patients commonly describe a quieted "food noise."
These medications require ongoing use to maintain effect for most patients — clinical trial data has shown substantial weight regain after discontinuation in many participants, which has shifted how physicians frame them: closer to a long-term chronic disease management medication than a short-course treatment.
This article is general health information, not medical advice, and doesn’t replace evaluation by your own physician. Talk to a doctor about anything specific to your own diagnosis or treatment.